Tislelizumab plus chemotherapy as first-line treatment for recurrent or metastatic nasopharyngeal cancer: A multicenter phase 3 trial (RATIONALE-309).
暂无分享，去创建一个
Hong Wang | Jianji Pan | Xiaozhong Chen | Zhixiong Lin | Chaosu Hu | Li Zhang | W. Fang | Yun-peng Yang | Si-yang Wang | Xiaopeng Ma | Yan Sun | Kunyu Yang | Yuanyuan Zhao | S. Leaw | Ye Guo | Lizhu Lin | N. Chen | Jiyu Wen | L. Liang | Qitao Yu | S. Qu | Xiaoming Huang | Yun Zhang | Feng Lei | Cheng Chen | Yanjie Wu | Guihua Wang | XIAO-YANG He | Shaoqing Chen | Fan Bai | Yunpeng Yang